跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,823 条关于
“Parabolus Medicines”
全部
9,823
临床试验
3,125
药物
371
机构
500
资讯
5,827
9天前
Parabolus Medicines' zolocatetide posts 74% response rate in desmoid tumors, targeting the undruggable beta-catenin/TCF complex
去年
Parabilis Medicines Demonstrates First-Ever Degradation of ERG in Prostate Cancer Models
去年
EMA's CHMP Recommends Approval for Ten New Medicines
去年
Parabilis Medicines Appoints Fawzi Benzaghou as Chief Medical Officer to Advance "Undruggable" Cancer Targets
上个月
BeOne Medicines and Revolution Medicines Forge Multi-Part Collaboration to Advance RAS(ON) Inhibitors for RAS-Addicted Cancers
去年
Stylus Medicine Emerges with $85M to Revolutionize In Vivo Genetic Medicines
11个月前
Parabilis Medicines Achieves First-Ever Clinical Success Targeting "Undruggable" β-Catenin:TCF Interaction with FOG-001
2年前
EMA's Advisory Group to Review Lecanemab for Alzheimer's Treatment
去年
EMA Grants Orphan Drug Designation to Ocugen's OCU410ST for ABCA4-Associated Retinopathies
8个月前
Parabilis Medicines Secures $305 Million Series F to Advance First-in-Class β-Catenin Inhibitor Zolucatetide
第 1 页,共 583 页
上一页
下一页